Natasha Marie Bernadette Archer

Boston Children'S Hospital

$841,200

Attributed

$841,200

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $169.4K · FY2020–24

$200K$150K$100K$50K$0

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$841,200 · 1

By mechanism

K08$841,200 · 1

Top collaborators

No co-investigators on record.

Most similar at Boston Children'S Hospital

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Affect”

Chanza Baytop · Westat, Inc.$271,217,917
Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
George Robert Painter · University Of Alabama At Birmingham$27,619,145
Jessica Brooke Langbaum · Banner Health$22,633,312

Research focus

AffectAfricaAlpha-ThalassemiaAreaAwardBindingBostonCareerCell CycleCell Cycle StageCellsCell TypeCellular AssayCellular BiologyCessation Of LifeChildClinically RelevantCommunitiesComorbidityCoupledDigestionDisease OutcomeDna BiosynthesisAdvisory Committees

Grant awards (5)

Red blood cell modifiers for Plasmodium falciparum growth in sickle cell disease erythrocytes$167,940

K08 · FY2024 · DK · contact PI

Red blood cell modifiers for Plasmodium falciparum growth in sickle cell disease erythrocytes$167,940

K08 · FY2023 · DK · contact PI

Red blood cell modifiers for Plasmodium falciparum growth in sickle cell disease erythrocytes$167,940

K08 · FY2022 · DK · contact PI

Red blood cell modifiers for Plasmodium falciparum growth in sickle cell disease erythrocytes$167,940

K08 · FY2021 · DK · contact PI

Red blood cell modifiers for Plasmodium falciparum growth in sickle cell disease erythrocytes$169,440

K08 · FY2020 · DK · contact PI